Before We Start
Latency — why herpes infections are never actually cured
Unlike most viral infections, where the immune system eventually clears the virus completely, herpesviruses do something different: after the initial (primary) infection, the virus doesn't get eliminated — it goes dormant inside specific host cells, hiding from the immune system in a state called latency. The viral genome sits quietly inside the host cell, largely inactive, for months, years, or decades.
Reactivation happens when something disrupts that quiet state — most often a drop in immune surveillance, whether from stress, illness, UV exposure, or actual immunosuppression. When the virus reactivates, it starts actively replicating again, and depending on which herpesvirus it is and where it was hiding, that reactivation can look like anything from a cold sore to a life-threatening infection in a transplant patient.
💡 Memory Trick
"Herpes never leaves." Four viruses, four different hiding spots, four different reactivation pictures — but the underlying pattern is identical every time: establish latency, wait, reactivate when immunity drops.
HSV hides in sensory ganglia. VZV hides in dorsal root ganglia. EBV hides in B lymphocytes. CMV hides in myeloid cells. Match the hiding spot to the virus, and the reactivation disease practically names itself.
The Four Herpesviruses
Latency site, primary infection, and reactivation disease — all four
HSV
Sensory ganglia — cold sores and genital lesions
HSV-1 and HSV-2 establish latency in sensory ganglia — specifically the trigeminal ganglion (for infections around the face and mouth) or the sacral ganglia (for genital infections). Primary infection often goes unnoticed or causes a mild initial outbreak; the virus then travels along sensory nerve fibers back to the ganglion and settles in for the long term.
Reactivation: Triggered specifically by stress, UV light exposure (sunlight is a well-documented trigger for facial cold sores), fever, or immunosuppression. When HSV reactivates, it travels back down the same nerve fibers to the skin or mucosal surface, producing the characteristic cold sore (HSV-1, typically) or genital lesion (HSV-2, typically) — though either type can technically cause either presentation depending on the site of initial exposure.
🦠 A person under significant stress or after a day of heavy sun exposure developing a cold sore days later is a textbook HSV-1 reactivation — the virus traveling back down the trigeminal nerve from where it's been hiding since the original infection, often years earlier.
VZV
Dorsal root ganglia — chickenpox, then shingles
Varicella-zoster virus causes chickenpox as its primary infection — typically in childhood, spreading as a widespread, itchy vesicular rash. After the primary infection resolves, VZV establishes latency in the dorsal root ganglia (the sensory nerve clusters running alongside the spinal cord).
Reactivation: Occurs later in life, most often as immune function naturally declines with age or drops due to illness or immunosuppression. Unlike the widespread rash of chickenpox, reactivated VZV — now called shingles (herpes zoster) — travels down just one sensory nerve root, producing a painful, blistering rash confined to a single dermatome (the strip of skin supplied by one specific spinal nerve), almost always on just one side of the body.
🦠 An older adult developing a painful, band-like rash confined to one side of their torso, following a single dermatome, is the classic presentation of shingles — VZV reactivating from a single dorsal root ganglion it's occupied since a childhood chickenpox infection decades earlier.
EBV
B lymphocytes — mononucleosis, and a real lymphoma risk
Epstein-Barr virus takes a fundamentally different approach to latency than HSV or VZV: rather than hiding in a nerve cell, EBV infects and establishes latency directly inside B lymphocytes, a key cell type of the adaptive immune system. Primary infection classically causes infectious mononucleosis, presenting with the well-known triad of fever, sore throat (pharyngitis), and swollen lymph nodes (lymphadenopathy) — most often in adolescents and young adults.
Reactivation and long-term risk: Because EBV persists specifically inside B lymphocytes — the very cells responsible for antibody production — chronic or reactivated EBV infection in immunocompromised individuals carries a genuine association with certain B-cell lymphomas. This is a meaningfully different risk profile than the other three herpesviruses discussed here, which don't carry this same direct cancer association.
🦠 A young adult presenting with the classic mononucleosis triad — fever, pharyngitis, lymphadenopathy — reflects primary EBV infection; the specific link to B-cell lymphoma later in life is a direct consequence of exactly where this virus chooses to hide.
CMV
Myeloid cells — usually silent, dangerous in transplant recipients
Cytomegalovirus establishes latency within cells of the myeloid lineage — bone marrow-derived progenitor cells that go on to become monocytes, macrophages, and dendritic cells. In a healthy, immunocompetent person, both primary CMV infection and any later reactivation are usually mild or entirely asymptomatic — most people who carry CMV never know it.
Why it matters clinically: That picture changes dramatically in transplant recipients and other significantly immunosuppressed patients. Because these patients are placed on immunosuppressive medication specifically to prevent organ rejection, their immune system loses the surveillance needed to keep CMV suppressed — reactivation in this population can cause serious, even life-threatening disease (pneumonitis, retinitis, colitis, and more), which is why transplant patients are routinely monitored for CMV reactivation as a standard part of their post-transplant care.
🦠 A transplant recipient on immunosuppressive therapy being closely monitored with regular CMV testing reflects exactly this risk — the same virus that would cause a healthy person no symptoms at all can become a serious threat once the immune system's usual control over it is deliberately suppressed.
🏥 Applied Scenario
An older adult presents with a painful, band-like rash confined to one side of their body, following a single dermatome. A student asks which herpesvirus and which latency site is most likely responsible — and how this would differ if the presentation were a cold sore instead.
Step 1
Identify the virus from the presentation: The single-dermatome, band-like distribution is the defining clue. This pattern points to VZV reactivating from its latent site in the dorsal root ganglia — this is the classic presentation of shingles, not a new infection but a reactivation of a virus that's been present since a childhood chickenpox infection.
Step 2
Contrast with a different presentation: If this same patient instead presented with a cold sore following a stressful period, the more likely culprit would be HSV-1 reactivating from the trigeminal ganglion instead — a different herpesvirus, hiding in a different location, triggered by a different (though related) kind of immune disruption.
Step 3
Explain why the latency site matters so much: Knowing each herpesvirus's specific latency site — sensory ganglia for HSV, dorsal root ganglia for VZV, B lymphocytes for EBV, myeloid cells for CMV — lets you predict both the reactivation trigger and the resulting clinical presentation before running a single test, just from where the rash or symptom shows up.
Step 4
Conclusion: Same underlying biological pattern (latency, then reactivation under immune pressure) across all four viruses — but the specific hiding place is what determines whether the outcome is a localized skin rash, a case of mono, or a serious infection risk unique to transplant patients.
📌 Exam Application
Herpesvirus latency is frequently tested as a matching/reasoning exercise:
Site matching: "Match each herpesvirus (HSV, VZV, EBV, CMV) to its latency site" — expect the four sites (sensory ganglia, dorsal root ganglia, B lymphocytes, myeloid cells) to be given out of order.
Presentation reasoning: "A patient develops a painful rash in a single dermatomal band. Which virus and which mechanism explains this?" → VZV reactivating from the dorsal root ganglia — the single-dermatome pattern reflects the single nerve root the virus was hiding in.
Population-specific risk: "Why are transplant recipients specifically monitored for CMV?" → Because their required immunosuppressive therapy removes the immune surveillance that normally keeps latent CMV suppressed, allowing reactivation with potentially serious disease.
Long-term risk distinction: "Which herpesvirus's latency site directly explains a specific cancer risk?" → EBV — its latency inside B lymphocytes specifically is what links chronic/reactivated infection to certain B-cell lymphomas.
⚠️ The Trap — Treating Chickenpox and Shingles as Different Viruses
A very common trap is treating chickenpox and shingles as though they were caused by two different viruses, since they look and feel so different clinically — one is a widespread childhood rash, the other a painful band-like eruption almost exclusively in adults.
Why this is wrong: They are the same virus, VZV, at two entirely different stages of the same lifelong infection. Chickenpox is what happens during primary infection, when the virus is spreading widely through the body for the first time. Shingles is what happens years or decades later, when that same virus — which never left, having been hiding quietly in the dorsal root ganglia the entire time — reactivates and travels back down a single nerve root.
How to avoid the trap: Ask "is this the first exposure, or a reactivation of a virus that's already present?" A widespread, generalized rash in a child who's never had it before is primary infection (chickenpox). A localized, single-dermatome rash — especially in an older adult or someone immunosuppressed — is reactivation of a virus already resident in that person's body (shingles), not a new infection at all.
✓ Quick Self-Test
Answer before checking:
1. Where does HSV-1/2 establish latency?
2. Where does VZV establish latency, and what does its reactivation cause?
3. Where does EBV establish latency, and what is a key long-term reactivation risk?
4. Where does CMV establish latency, and in what population is reactivation especially dangerous?
5. Name three common triggers for herpesvirus reactivation.
Answers:
1. The trigeminal or sacral sensory ganglia, depending on the site of the original infection.
2. The dorsal root ganglia; reactivation causes shingles (herpes zoster), presenting in a single-dermatome distribution rather than the widespread rash of the original chickenpox infection.
3. B lymphocytes; reactivation or chronic infection in immunocompromised individuals carries a real association with certain B-cell lymphomas.
4. Myeloid cells (bone marrow-derived progenitors of monocytes, macrophages, and dendritic cells); especially dangerous in transplant recipients, whose required immunosuppressive therapy removes the immune control that normally keeps CMV suppressed.
5. Stress, UV light exposure, and immunosuppression (illness, medication, or age-related immune decline) — any of these can trigger reactivation, depending on the specific virus.